On Thursday, Level 3 Communications, Inc. (NYSE:LVLT)’s shares declined -1.32% to $52.43.
Global telecommunications provider Level 3 Communications, Inc., (LVLT) declared the formation of the Level 3 Foundation Inc., a 501(c)(3) public charity. The Foundation was established to amplify the efforts of Level 3 Cares, the company’s corporate social responsibility program that launched in 2012, and give back to the communities where its employees live and work.
The mission of the Foundation is to provide employees and community members the opportunity to be kind to their neighbors and share in the company’s commitment to giving back. Both company employees and community members can contribute financially to the Foundation to support any of the identified cause areas: animal welfare, arts and culture, disaster relief, education, health and disease, natural environment and the underprivileged. Level 3 will match up to $250,000 of all employee contributions made to the Level 3 Foundation this year.
Level 3 believes a company culture based on core values not only assists its business, but also defines the role it can play in society. These core values – accountability, integrity, performance, respect, service and teamwork – assisted lay the groundwork for the Foundation and its mission.
The Foundation’s Board of Directors is comprised of three members, Tom Stortz, president and Chairman of the Board, Laurinda Pang, vice president, and Sondra Smith, secretary.
Level 3 Communications, Inc., together with its auxiliaries, operates as a facilities-based provider of a range of integrated communications services primarily in North America, Latin America, Europe, the Middle East, and Africa. The company provides transport services comprising wavelengths, private lines, transoceanic, and dark fiber, in addition to related professional services; fiber services; and colocation and data center services, such as cloud, hosting, and application administration solutions. It also offers Internet protocol (IP) and data services comprising Internet services, virtual private network, content delivery network, media delivery, Vyvx broadcast, converged business network, and managed services; local and enterprise voice services comprising of voice over IP improved local, SIP trunking, local inbound, primary rate interface, long distance, and toll free services; and partnership services, such as audio, Web, and video conferencing services. In addition, the company provides wholesale voice services, counting voice termination and toll free services.
Mobile TeleSystems OJSC (ADR) (NYSE:MBT)’s shares dropped -0.92% to $9.17.
Mobile TeleSystems OJSC (ADR) (MBT) a global consulting, technology services and outsourcing company, declared that it was named to the “25 Most Promising Cloud Services Vendors 2015” in the latest issue of Outsourcing Gazette, a print magazine which provides a platform to thinkers, practitioners, strategists and visionaries in the outsourcing community. Among the leading service providers dominating the landscape in the cloud space recently, Bell Integrator stood out as the “Company of the Month.”
By presenting the “25 Most Promising Cloud Services Vendors,” Outsourcing Gazette’s aim is to educate its audience about best of breed service providers for their needs and to assist CIOs select the right service provider from literally hundreds of vendors providing almost similar services.
A distinguished panel of CEOs, CIOs, Analysts and Industry Experts together with the Outsourcing Gazette editorial team selected Bell Integrator to the list noting the company’s service offering, core competencies, client testimonials and other industry recognitions.
Most recently Bell Integrator was honored with the IBM’s Best Partner Award in the IBM Cloud for Telecom category. These recognitions highlight Bell Integrator’s expertise and achievements in the cloud computing market.
Mobile TeleSystems OJSC provides telecommunication services in Russia and the Commonwealth of Independent States. The company offers a range of mobile and fixed line voice and data telecommunications services, counting data transfer, broadband, pay-TV, and various value-added services, in addition to sells equipment and accessories.
At the end of Thursday’s trade, Amgen, Inc. (NASDAQ:AMGN)‘s shares dipped -1.12% to $153.26.
Amgen (AMGN) declared positive interim results from its open-label extension of the global Phase 2, double-blind, placebo-controlled study evaluating the safety and efficacy of AMG 334 for the prevention of episodic migraine. Patients who entered the open-label phase received AMG 334 70 mg monthly and practiced a sustained reduction in monthly migraine days at week 52.
At one year, patients receiving AMG 334 70 mg practiced an average of a -4.9-day reduction from a baseline of 8.7 mean monthly migraine days, regardless of treatment received during the blinded phase. The 50 percent responder rate (greater than 50 percent reduction in monthly migraine days) was 62 percent at 52 weeks. Additional responder rates were stated for the first time: at 52 weeks the 75 percent responder rate was 38 percent and the 100 percent responder rate was 19 percent.
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine. The company’s principal products comprise Neulasta, a pegylated protein to decrease the incidence of infection associated with chemotherapy-induced febrile neutropenia in cancer patients; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for reducing the incidence of infection as manifested by febrile neutropenia for patients with non-myeloid malignancies; and Enbrel to treat rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis in adult patients. Its principal products also comprise EPOGEN for the treatment of dialysis; Aranesp for treating anemia; XGEVA for the prevention of skeletal-related events; Prolia to treat postmenopausal women with osteoporosis; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in chronic kidney disease patients on dialysis. The company’s other marketed products comprise Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; Vectibix, a human monoclonal antibody; and BLINCYTO for the treatment of patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It also develops various products that are in various clinical trials.
Gap Inc (NYSE:GPS), ended its Thursday’s trading session with 0.46% gain, and closed at $38.62.
Gap Inc (GPS) declared a series of planned actions to position Gap brand for improved business performance and build for the future. Following a thorough evaluation of its business and operations, Gap plans to right-size its specialty store fleet and streamline its headquarter workforce, primarily in North America, as part of the comprehensive effort to deliver more compriseent and compelling product collections and engage customers across all channels.
In order to drive productivity improvements and showcase the brand in the most successful locations, Gap will close about 175 specialty stores in North America over the next few years, with about 140 closures occurring this fiscal year. These changes will not impact Gap Outlet and Gap Factory Stores. In parallel with these moves, the brand will close a limited number of European stores during this period.
Following the fleet optimization effort, the brand will continue to serve North American customers through about 800 Gap stores – comprised of 500 Gap specialty locations and 300 Gap outlet stores – in addition to its dynamic online channels, better reflecting the way recently customers shop across specialty, outlet and online. The brand will continue to have a robust global presence in more than 50 countries and with about 1,600 company-operated and franchise locations globally.
The Gap, Inc. operates as an apparel retail company worldwide. It offers apparel, accessories, and personal care products for men, women, and children under the Gap, Banana Republic, Old Navy, Athleta, and Intermix brand names. The company provides apparel, handbags, shoes, jewelry, personal care products, and eyewear for men and women; and performance and lifestyle apparel for use in yoga, strength training, and running, as well as seasonal sports, including skiing and tennis. It offers its products through company-operated stores, franchise stores, Websites, e-commerce and social sites, and catalogs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
